317. Trifunctional protein deficiency Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 9 - (DrugBank : 4) / Drug target gene : 1 - Drug target pathway : 1
Trifunctional protein deficiency and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 317 | Trifunctional protein deficiency | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.000 |
| 299 | Cystic fibrosis | 1.000 |
| 46 | Malignant rheumatoid arthritis | 1.000 |
| 51 | Scleroderma | 1.000 |
| 60 | Aplastic anemia | 1.000 |
| 84 | Sarcoidosis | 1.000 |
| 280 | Huge arteriovenous malformation with cervicofacial or limb lesion | 1.000 |
| 271 | Ankylosing spondylitis | 1.000 |
| 79 | Homozygous familial hypercholesterolemia | 1.000 |
| 107 | Juvenile idiopathic arthritis | 1.000 |
| 97 | Ulcerative colitis | 1.000 |
| 316 | Carnitine cycle disorder | 1.000 |
| 226 | Interstitial cystitis with Hunners ulcer | 1.000 |
| 70 | Spinal stenosis | 1.000 |
| 224 | Purpura nephritis | 1.000 |
| 288 | Autoimmune acquired coagulation factor deficiency | 1.000 |
| 47 | Buerger disease | 1.000 |